Narjust Duma, MD

Narjust Duma, MD, discusses the importance of mitigating racial disparities in lung cancer research. 

Outbreaks of coronavirus disease 2019 are on the rise in Latin America, with more than 4 million confirmed cases. In response to this health crisis, elective medical procedures, including cancer screening and care, as well as treatment for conditions beyond the virus, have been held.

Data suggest that up to 95% of patients with lung cancer score below the fiftieth percentile on sexual function during and after completion of cancer-directed therapy.

Narjust Duma, MD, shares her experience with being tested for COVID-19 and discusses the lasting implications of the pandemic.

As oncologists, we often rely on guidelines to make treatment decisions; however, none of those guidelines include dealing with a pandemic such as COVID-19.

Narjust Duma, MD, shares her personal experience with feeling ill during the COVID-19 pandemic.

Narjust Duma, MD, shares some of her experiences while looking for her first faculty position in medical oncology. This information is not unique to hematology-medical oncology and may be helpful to fellows from other specialties.

Study results demonstrate that men and women differ in their immunological responses to foreign and self-antigens.

Candace Haddox, MD, and Narjust Duma, MD, address the uncertainty, the victories, and the defeats common in oncology fellowship programs.